Today: 10 June 2026
Coca-Cola HBC Raises €2.1 Billion in Euro Bonds as Africa Deal Moves Ahead
27 March 2026
2 mins read

Coca-Cola HBC Raises €2.1 Billion in Euro Bonds as Africa Deal Moves Ahead

LONDON, March 27, 2026, 19:56 GMT

Coca-Cola HBC landed a 2.1 billion euro bond deal Thursday, pulling in over 7.1 billion euros in orders—well above the 1.5 billion euros the company initially targeted. As the books swelled, pricing was cut back by no less than 0.30 percentage points from where talks began.

Coca-Cola HBC plans to use the deal’s proceeds to cover general financing and refinancing, plus the cash portion tied to its planned buyout of Coca-Cola Beverages Africa, or CCBA. The move locks in a funding route for what’s set to be the company’s largest expansion in recent years, with the acquisition still on track to wrap up by the end of 2026.

In October, Coca-Cola HBC struck a $2.6 billion deal to acquire a 75% stake in CCBA. The target runs operations across 14 African countries and represents roughly 40% of Coca-Cola system volumes sold in Africa; with the deal’s closure, Coca-Cola HBC would jump to the number-two spot among Coke bottlers by volume, trailing only Coca-Cola FEMSA. That’s according to company statements and reporting from Reuters.

The bonds landed in three tranches: 700 million euros maturing 2028 with a 3.375% coupon, 600 million euros due 2030 at 3.625%, and a final 800 million euros stretching to 2033 at 4.000%. Settlement is slated for April 1, according to Coca-Cola HBC, and the notes are headed for a London listing under its 10 billion euro Euro Medium Term Note programme—an ongoing vehicle for repeated bond issuance.

Coca-Cola HBC enters the market with modest leverage. For 2025, revenue landed at 11.6 billion euros, with organic EBIT up 11.5%. Net debt sits at just 0.7 times comparable adjusted EBITDA, the typical metric investors watch for debt load. In February, the company guided for 7% to 10% organic operating profit growth in 2026.

Zoran Bogdanovic, the chief executive, has been making the pitch for months. Back in February, he told Reuters the company was “constantly monitoring consumer sentiment” in its markets. In a separate comment, he pointed to “a deep understanding of Africa” built over years in Nigeria and since acquiring operations in Egypt in 2022. Reuters

Coca-Cola HBC originally planned to use a bridge loan for the cash portion of the CCBA deal, along with issuing new shares to Gutsche Family Investments—taking their stake to 5.47% of the expanded group. Now with the new bond sale, some of that financing looks to be moving onto longer-term debt, trimming reliance on the short-dated bridge.

Still, the financing doesn’t clear away the key hurdles. The CCBA deal is waiting on regulatory and antitrust sign-off; plus, Coca-Cola HBC holds an option to snap up the company’s remaining 25% stake over the next six years—a move that could call for extra capital down the line. S&P Global Ratings tagged the planned notes with a BBB+ issue rating, estimating pro forma debt to EBITDA will run about 2.1x to 2.2x in 2026, with only modest deleveraging expected after that.

The company has shifted gears, moving past the Africa deal announcement to securing long-term financing. Dutch subsidiary Coca-Cola HBC Finance B.V. is issuing the notes, backed by a guarantee from Swiss-based parent Coca-Cola HBC AG.

Stock Market Today

  • Palantir Technologies (PLTR) Shares Seen Fairly Valued Amid Recent Decline
    June 10, 2026, 5:48 PM EDT. Palantir Technologies has seen its share price fall 13.2% over the past week and 21.3% year to date, following extraordinary gains in prior years. At $132.07 per share, Palantir trades slightly below its estimated intrinsic value of $145.11 based on a Discounted Cash Flow (DCF) analysis, suggesting a modest 9% discount. The company posted $2.69 billion in free cash flow over the past twelve months, with projections rising to $16.11 billion by 2030. Despite recent volatility tied to sentiment on artificial intelligence and software spending, Palantir remains fairly valued but not a clear bargain. Investors should monitor further market developments and valuation metrics to gauge future opportunities or risks.

Latest articles

Parabilis Medicines (PBLS) soars 58% after $670 million IPO beats range

Parabilis Medicines (PBLS) soars 58% after $670 million IPO beats range

10 June 2026
Parabilis Medicines soared 58% above its $20 IPO price to close at $31.60 in its Nasdaq debut after raising a record $670 million, reflecting strong investor demand for its Helicon drug platform ahead of a pivotal Phase 3 desmoid tumor trial planned for 2027; Regeneron’s $75 million private placement added credibility.
Joby Aviation Shares Slip After CFO Files to Sell Stock

Joby Aviation Shares Slip After CFO Files to Sell Stock

10 June 2026
Joby Aviation fell 4.47% to $8.86 after CFO Rodrigo Brumana disclosed selling 78,489 shares under a prearranged 10b5-1 plan, with no new certification or commercial-launch updates, leaving investors focused on regulatory progress and cash burn as the key catalysts for the stock.
YY Group Shares Spike as Humanoid Robot Plans Unveiled

YY Group Shares Spike as Humanoid Robot Plans Unveiled

10 June 2026
YY Group Holding shares surged to $0.165 on heavy volume after announcing a commercial humanoid-robotics initiative using Unitree G1 robots and facility-management data, reframing the company as a robotics-and-AI data play; the rally comes despite 2025 net loss, dilution risk from a relaunched at-the-market share-sale program, and no disclosed robot-related revenue or contracts.
UnitedHealth Stock Slides Again as April Earnings Loom, Putting UNH Valuation Under New Scrutiny
Previous Story

UnitedHealth Stock Slides Again as April Earnings Loom, Putting UNH Valuation Under New Scrutiny

Plug Power Stock Price Today: Shares Slip as New CEO Repeats Profit Roadmap
Next Story

Plug Power Stock Price Today: Shares Slip as New CEO Repeats Profit Roadmap

Go toTop